SCHEMBL120920

SCHEMBL120920

CCC1OC(=O)C(O)=C1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 2/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LMNA P02545 2/20 0.33
MAOA P21397 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PTPN1 P18031 2/20 0.33
ACP1 P24666 1/20 0.33
CDC25B P30305 1/20 0.33
RECQL P46063 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PTPN2 P17706 1/20 0.33
DUSP3 P51452 1/20 0.33
HPSE Q9Y251 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CES2 O00748 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5359081 0.83 KAT2A (0.39) MAPTKDM4ETP53MAPK1CYP2C19
SCHEMBL5361290 0.80 CES2 (0.44) MAPTKDM4EMAOAPTPN1ACP1
SCHEMBL6929222 0.80 MAPT (0.42) MAPTKDM4ETP53MAPK1CYP2C19
SCHEMBL5354001 0.78 MAPT (0.34) MAPTKDM4ETP53MAPK1CYP2C19
SCHEMBL5351324 0.77 KDM4E (0.33) MAPTKDM4ELMNAL3MBTL1PTPN1
SCHEMBL15962403 0.74 PTPN1 (0.36) MAPTKDM4ETP53MAPK1CYP2C19
SCHEMBL13176951 0.74 PTPN1 (0.36) MAPTKDM4ETP53MAPK1CYP2C19
SCHEMBL8749939 0.70
SCHEMBL112481 0.70 MAPT (0.34) MAPTKDM4ETP53MAPK1CYP2C19
SCHEMBL15681491 0.70 MAPT (0.34) MAPTKDM4ETP53MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12568998-B2 Flavouring composition with balanced taste profile SYMRISE AG (DE) 2026-03-10 US claimed
EP-4672967-A2 ALTERNATIVE COFFEE BEVERAGES Compound Foods Inc. (US) 2026-01-07 EP claimed
US-12496370-B2 Freshening compositions comprising controlled release modulators Arylessence, Inc. (US) 2025-12-16 US claimed
WO-2025226566-A1 INSTANT WHITE COFFEE STARBUCKS CORPORATION (US) 2025-10-30 WO claimed
WO-2025226563-A1 METHODS FOR PRODUCING INSTANT WHITE COFFEE STARBUCKS CORPORATION (US) 2025-10-30 WO claimed
US-20250324996-A1 Instant White Coffee STARBUCKS CORPORATION 2025-10-23 US claimed
US-20250324997-A1 Methods for Producing Instant White Coffee STARBUCKS CORPORATION 2025-10-23 US claimed
EP-4615958-A1 CELL COMPOSITIONS Givaudan SA (CH) 2025-09-17 EP claimed
EP-4444108-B1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT SYMRISE AG (DE) 2025-09-10 EP claimed
EP-4565194-A1 ODOR AND COLORANT STABILIZED COMPOSITIONS Symrise AG (DE) 2025-06-11 EP claimed
EP-1457547-A1 ODORANT FOR FUEL GAS SODA AROMATIC COMPANY, LIMITED (JP) 2004-09-15 EP claimed
EP-1451334-A2 PRODUCTION OF ALPHA-KETO BUTYRATE Société des Produits Nestlé S.A. (CH) 2004-09-01 EP claimed
WO-2004047572-A1 WRAPPING MATERIALS FOR SMOKING ARTICLES R.J. REYNOLDS TOBACCO COMPANY (US) 2004-06-10 WO claimed
EP-1425977-A1 FLAVORING MATERIALS AND FOODS AND DRINKS CONTAINING THE SAME Ajinomoto Co., Inc. (JP) 2004-06-09 EP claimed
US-20040099280-A1 Wrapping materials for smoking articles JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2004-05-27 US claimed
WO-2003101216-A2 COFFEE AROMA HAVING AN IMPROVED STABILITY SYMRISE GMBH & CO. KG (DE) 2003-12-11 WO claimed
WO-2003046193-A2 PRODUCTION OF α-KETO BUTYRATE SOCIETE DES PRODUITS NESTLE S.A. (CH) 2003-06-05 WO claimed
EP-0731648-B1 FLAVOURING COMPOSITIONS AND METHOD FIRMENICH & CIE (CH) 2003-03-26 EP claimed
US-6296889-B1 Use of 1-nonen-3-one for aroma/flavor enhancement NESTEC S.A. (CH) 2001-10-02 US claimed
US-6287620-B1 Flavor enhancing methods FIRMENICH SA (CH) 2001-09-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12568998-B2 Flavouring composition with balanced taste profile TAS2R20, TAS2R50, TAS2R40 MAPT 3611/4885KDM4E 4345/4885TP53 3048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.